Tags: 
Akebia Therapeutics, a biopharmaceutical company focused on the development of novel proprietary therapeutics, signed an eight-year lease for an additional 19,805 square feet of office space at the Kendall Square building at 245 First St. in Cambridge, MA.
Akebia has been a tenant in the 18-story, 311,500-square-foot building since 2013, according to CoStar information. With the lease, the company will now also occupy the 12th floor formerly home…
Article From: "Key Realty Commercial Real Estate News" Read full article